Use of the Uteroglobin Platform for the Expression of a Bivalent Antibody against Oncofetal Fibronectin in Escherichia coli

• Elisa Ventura,

  Affiliation Laboratory of Oncology, G. Gaslini Institute, Genova, Italy

  ⨯
• Mattia Riondato,

  Affiliation Department of Health Science, Nuclear Medicine, University of Genoa, IRCCS AOU San Martino - IST, Genova, Italy

  ⨯
• Gianmario Sambuceti,

  Affiliation Department of Health Science, Nuclear Medicine, University of Genoa, IRCCS AOU San Martino - IST, Genova, Italy

  ⨯
• Annalisa Salis,

  Affiliation Department of Hearth, Environmental and Life Science, Center for Excellence in Biomedical Research, Genova, Italy

  ⨯
• Gianluca Damonte,

  Affiliation Department of Experimental Medicine and Center for Excellence in Biomedical Research, Genova, Italy

  ⨯
• Cinzia Cordazzo,

  Affiliation Sirius-biotech, c/o Advanced Biotechnology Center, Genova, Italy

  ⨯
• Hüseyin Besir,

  Affiliation Protein Expression and Purification Core Facility, EMBL Heidelberg, Heidelberg, Germany

  ⨯
• Vito Pistoia,

  Affiliation Laboratory of Oncology, G. Gaslini Institute, Genova, Italy

  ⨯
• Luciano Zardi

  * E-mail: luciano.zardi@sirius-biotech.com

  Affiliation Sirius-biotech, c/o Advanced Biotechnology Center, Genova, Italy

  ⨯